Impact of Follicular and Blood G-CSF During a Natural Cycle of IVF

Terminated

• Conditions: Infertility
• Interventions: Procedure: Blood test

• Registration Number: NCT01668225
• Lead Sponsor: Clinique Ovo

Brief Summary

Recently, scientists look into G-CSF (Granulocyte - Colony Stimulatin Factor). The use of this molecule is increasing in reproduction pathology. High level of follicular and blood G-CSF on the day of oocyte retrieval could correlate with higher pregnancy and implantation rates.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-03
• Study First Submitted: 2012-06-19
• Study First Submitted QC: 2012-08-14
• Study First Posted: 2012-08-20
• Primary Completion: 2017-01
• Study Completion: 2017-01
• Status Verified: 2022-09
• Last Update Submitted: 2022-09-08
• Last Update Posted: 2022-09-10

Recruitment & Eligibility

• Status: TERMINATED
• Sex: Female
• Target Recruitment: 152

Inclusion Criteria

• Women between 18 and 43 years old
• Women natural In Vitro Fecondation

Exclusion Criteria

• No exclusion criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
G-CSF FIV nat	Blood test	Patient following a natural In Vitro Fecondation cycle

Primary Outcome Measures

Name	Time	Method
Serum and / or follicular minimum level of G-CSF predictive of pregnancy	6 months

Trial Locations

Locations (1)

Ovo Fertilité; 🇨🇦 Montréal, Quebec, Canada